Security record · archived quarter
MD
Pediatrix Medical Group, Inc. · Healthcare · Medical - Care Facilities
1Tracked holders
0Δ holders
14.44KShares held
$378,853Reported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2026
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 14.44K | $378,853 | n/a | n/a |
| Q2 2026 | 95 | -3 | 57.21M | $1.45B | +5 | −10 |
| Q1 2026 | 103 | +4 | 59.12M | $1.26B | +9 | −5 |
| Q4 2025 | 99 | -1 | 67.55M | $1.45B | n/a | −1 |
| Q3 2025 | 18 | +1 | 40.93M | $685.43M | +1 | n/a |
| Q2 2025 | 14 | 0 | 37.94M | $544.34M | +2 | −2 |
| Q1 2025 | 11 | +1 | 9.91M | $143.46M | +1 | n/a |
| Q4 2024 | 10 | -3 | 9.74M | $127.83M | n/a | −3 |
| Q3 2024 | 12 | 0 | 6.92M | $79.97M | +1 | −1 |
| Q2 2024 | 12 | n/a | 7.89M | $59.29M | n/a | n/a |
Who holds it · Q3 2026
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wealth Enhancement Advisory… | 14.44K | +4.4% | $378,853 | 0.0% | ▲ Add | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 293 holders, 82.31M shares, $1.71B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Sep 03
SC 13G: VANGUARD CAPITAL MANAGEMENT LLC
Sep 03
SC 13G: VANGUARD PORTFOLIO MANAGEMENT LLC
Sep 03
SC 13G/A: VANGUARD GROUP INC
Jul 14
SC 13G: DIMENSIONAL FUND ADVISORS LP
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2026 ·
Methodology ·
Get this via the API